New studies show negative effects from revised mammography recommendation for women, ages 40-49

May 2, 2011 in Cancer

Two new studies reveal that the United States Preventative Services Task Force's (USPSTF) recommendation to no longer screen women ages 40-49 for breast cancer using mammograms has begun to negatively affect the number of yearly mammograms performed in this age group and thus decrease the benefits of early detection.

After the USPSTF delivered their recommendations in November 2009, researchers at the University of Colorado saw a significant drop in in women in the 40-49 age range. "In the nine months after the guidelines, we saw 205 fewer women in the 40-49 age group than we did the previous year," says Dr. Lara Hardesty, lead researcher for this study.

Similarly, researchers at the University Hospitals at Case Medical Center conducted a retrospective review to determine the potential impact of forgoing in this patient population. "These guidelines greatly concerned us, especially for our patients and primary physicians, says Dr. Donna Plecha. "We know that when patients are screened earlier, they have a better prognosis for detection and treatment."

In the study at the University Hospitals at Case Medical Center, out of the 524 biopsies performed, 108 cases of cancer were diagnosed. Cancers found in the 40-49-year-old patients who underwent screening mammography presented at a much earlier stage of breast cancer than those patients who did not have screening mammograms. Dr. Plecha believes that if primary physicians and patients begin following the USPSTF's guidelines, survival rates in this population will decline. She says "Seventy percent of who are diagnosed with breast cancer don't have a family history of breast cancer. It's very important that we continue to do all that we can to catch in the earliest stages so that we can continue to save lives."

Dr. Hardesty also stresses the importance of emphasizing the benefits of yearly mammograms to 40-49 year old patients and physicians alike. She says, "We must continue to get the message out to our patients and make sure that referring providers understand our recommendations because they are the ones who are influencing patients in that age group."

Dr. Hardesty and Dr. Plecha will deliver presentations on their studies on Monday, May 2, 2011 at the 2011 ARRS Annual Meeting at the Hyatt Regency Chicago.

Provided by American Roentgen Ray Society

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts
  • A question about drug tolerance
    created4 hours ago
  • Poor nutrition leading to overeating?
    created22 hours ago
  • Math and dyslexia?
    createdMay 21, 2012
  • portable metabolism meter?
    createdMay 21, 2012
  • Rare medical conditions on 20/20 tonight
    createdMay 18, 2012
  • "Good" Cholesterol in Doubt
    createdMay 17, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Cancer docs often deal with own grief, doubts when patients die

(HealthDay) -- Some cancer doctors may build up emotional walls -- distancing themselves from the patients they can't save -- to avoid grief, sadness and even despair, new research shows.

Cancer created 9 hours ago | popularity not rated yet | comments 0 | with audio podcast

Regorafenib active in metastatic GI stromal tumors

(HealthDay) -- Regorafenib, an inhibitor of multiple cancer-associated kinases, is active in patients with metastatic gastrointestinal stromal tumors (GIST) who have failed to respond to imatinib and sunitinib, ...

Cancer created 9 hours ago | popularity not rated yet | comments 0

Robotic-assisted prostate cancer surgery drives up costs

In one of the most comprehensive analyses to date of the cost of robotic-assisted, laparoscopic surgery for prostate cancer, researchers at UPMC found that this now-dominant surgical approach is significantly more costly ...

Cancer created 11 hours ago | popularity not rated yet | comments 0

Cardio fitness levels of breast cancer patients may affect survival

Women receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical ...

Cancer created 11 hours ago | popularity not rated yet | comments 0 | with audio podcast

Breast MRI helps predict chemotherapy's effectiveness

Magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online ...

Cancer created 18 hours ago | popularity not rated yet | comments 0


The Goldilocks effect: Babies learn from experiences that are 'just right'

Long before babies understand the story of Goldilocks, they have more than mastered the fairy tale heroine's method of decision-making. Infants ignore information that is too simple or too complex, focusing instead on situations ...

Aspirin may prevent recurrence of deep vein blood clots

(HealthDay) -- After suffering a type of blood clot called a venous thromboembolism, patients usually take a blood-thinner such as warfarin (Coumadin). But aspirin may do just as well after a period of time, ...

Study shows how immune cells change wiring of the developing mouse brain

Researchers have shown in mice how immune cells in the brain target and remove unused connections between brain cells during normal development. This research, supported by the National Institutes of Health, sheds light on ...

Intrauterine devices, implants most effective birth control

A study to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than ...

Women trying to have babies face different clock problem

A new Northwestern University study shows that the biological clock is not the only clock women trying to conceive should consider. The circadian clock needs attention, too.

Whole genome sequencing of rare olfactory neuroblastoma

The Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have conducted whole genome sequencing (WGS) of a rare nasal tract cancer called olfactory neuroblastoma ...